To investigate the roles of CLPTM1L in cervical cancer cells, lentiviral vectors containing shRNA sequences designed to specifically silence the expression of CLPTM1L were constructed for infection of HeLa and C-33A cells. This evidence concerns the gene CLPTM1L and cervical carcinoma.